Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PainChek Ltd ( (AU:PCK) ) has issued an update.
PainChek Ltd has announced the application for quotation of 1,343,140 ordinary fully paid securities on the Australian Securities Exchange (ASX), following the exercise of options or conversion of other convertible securities. This move is likely to enhance the company’s financial flexibility and market presence, potentially impacting its operational capabilities and offering opportunities for stakeholders.
More about PainChek Ltd
PainChek Ltd is a company operating in the healthcare industry, focusing on the development and provision of pain assessment technologies. Their primary product is a pain assessment tool that utilizes facial recognition technology to evaluate pain levels in individuals who may have difficulty communicating their pain, such as those with dementia or cognitive impairments.
Average Trading Volume: 4,323,799
Technical Sentiment Signal: Buy
Current Market Cap: A$134.6M
For detailed information about PCK stock, go to TipRanks’ Stock Analysis page.